Stefan Trapp

Stefan Trapp

Auto-generated profile, based on publicly available information

Stefan Trapp

Technical University of Denmark, Kongens Lyngby, Denmark

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
STStefan Trapp
Stefan Trapp

1 September 1995 in Environmental Science & Technology
Verified
Journal Article
Closed access
STStefan. Trapp
Stefan. Trapp
MMMichael. Matthies
Michael. Matthies

8 August 2014 in Critical Reviews in Environmental Science and Technology
Verified
Journal Article
Closed access
MKMatthias Kästner
Matthias Kästner
KNKarolina M. Nowak
Karolina M. Nowak
AMAnja Miltner
Anja Miltner
STStefan Trapp
Stefan Trapp
ASAndreas Schäffer
Andreas Schäffer
This review provides a comprehensive overview about nonextractable residue (NER) formation and attempts to classify the various types. Xenobiotic NER derived from parent pesticides (or other environmental contaminants) and primary metabolites sorbed or entrapped within the soil organic matter (Type I) or covalently bound (Type II) pose a considerably higher risk than those derived from productive biodegradation. However, biogenic nonextractable residues (bioNER) (Type III) resulting from conversion of carbon (or nitrogen) from the compounds into microbial biomass molecules do not pose any risk. Experimental approaches to clearly distinguish between the types are provided, and a model to prospectively estimate bioNER formation in soil is proposed.


14 May 2005 in European Biophysics Journal
Verified
Journal Article
Closed access
PDF file
STStefan Trapp
Stefan Trapp
RHRichard W. Horobin
Richard W. Horobin

31 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JKJohannes Konrhuber
Johannes Konrhuber
MMMarkus Muehlbacher
Markus Muehlbacher
STStefan Trapp
Stefan Trapp
SPStefanie Pechmann
Stefanie Pechmann
AFAstrid Friedl
Astrid Friedl
PTPhilipp Tripal
Philipp Tripal
We describe a hitherto unknown feature for 27 small drug-like molecules, namely functional inhibition of acid sphingomyelinase (ASM). These entities named FIASMAs (Functional Inhibitors of Acid SphingoMyelinAse), therefore, can be potentially used to treat diseases associated with enhanced activity of ASM, such as Alzheimer's disease, major depression, radiation- and chemotherapy-induced apoptosis and endotoxic shock syndrome. Residual activity of ASM measured in the presence of 10 µM drug concentration shows a bimodal distribution; thus the tested drugs can be classified into two groups with lower and higher inhibitory activity. All FIASMAs share distinct physicochemical properties in showing lipophilic and weakly basic properties. Hierarchical clustering of Tanimoto coefficients revealed that FIASMAs occur among drugs of various chemical scaffolds. Moreover, FIASMAs more frequently violate Lipinski's Rule-of-Five than compounds without effect on ASM. Inhibition of ASM appears to be associated with good permeability across the blood-brain barrier. In the present investigation, we developed a novel structure-property-activity relationship by using a random forest-based binary classification learner. Virtual screening revealed that only six out of 768 (0.78%) compounds of natural products functionally inhibit ASM, whereas this inhibitory activity occurs in 135 out of 2028 (6.66%) drugs licensed for medical use in humans.